Amrita Therapeutics Limited - life sciences in Ahmedabad, Gujarat, India. Directors, charges & compliance details.
CIN U24239GJ2008PLC053030 Incorporated 25 February 2008 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Struck Off Public Limited Company life sciences
Authorised capital
₹3.5 Cr
Registered with MCA
Paid-up capital
₹2.4 Cr
Issued & subscribed
Company age
18 yrs
Est. 2008
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
Brands
1
Associated brands
Last financials
Mar 2018
Balance sheet date
Last AGM
29 Sep 2018
Annual general meeting

About Amrita Therapeutics Limited

Data last updated:

Amrita Therapeutics Limited was a public limited company based in Ahmedabad, Gujarat, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the biotechnology segment of the life sciences sector. It was incorporated on 25 February 2008.

The company was registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24239GJ2008PLC053030. Its GSTIN is 24AAHCA2520R1ZL (Gujarat).

The company had an authorised share capital of ₹3.5 Cr and a paid-up capital of ₹2.4 Cr. It was formerly known as Amrita Therapeutics Private Limited. It was led by directors including Himanshu Chimanlal Vyas and Susan Kling Finston.

Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Outer Room 11 Devipark Co – Op. Housing Society B/H Lake View Appt. Vastrapur., Ahmedabad, Gujarat, India – 380054.

The company was associated with 1 brand: Amrita Therapeutics. The company has 9 deals on record (5 funding rounds, 4 secondary share transfers), with disclosed funding of ₹3.77 Cr; the latest was in October 2015.

The last known website on record is amritatherapetics.com.

Company details

CIN U24239GJ2008PLC053030
Registration Number 053030
Incorporation Date 25 February 2008
ROC Ahmedabad
Listing Status Unlisted
Company Status Struck Off
Compliance Status Active Non-Compliant

CIN history

Amrita Therapeutics has one previous CIN (Corporate Identification Number): U24239GJ2008PTC053030. The current CIN is U24239GJ2008PLC053030, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239GJ2008PLC053030Current
U24239GJ2008PTC053030Previous

Contact details

Amrita Therapeutics Limited's registered office is in Ahmedabad, Gujarat. Its website is amritatherapetics.com. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Outer Room 11 Devipark Co – Op. Housing Society B/H Lake View Appt. Vastrapur., Ahmedabad, Gujarat, India – 380054
  • Industry
    Life Sciences, Biotechnology

To see the full contact details of Amrita Therapeutics Limited, buy the company report.

Comprehensive company report
Amrita Therapeutics Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Amrita Therapeutics operates one associated brand: Amrita Therapeutics. Each brand links to its own profile.

BrandDescriptionWebsite
Specializes in antibody production, therapeutic development, and diagnostic tools for labs and companies.amritatherapeutics.com

Financials of Amrita Therapeutics Limited

FY 2018 filings available

Financial Statement Summary

MetricsFY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Amrita Therapeutics Limited, buy the company report.

Board of directors of Amrita Therapeutics Limited

Amrita Therapeutics has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Himanshu Chimanlal VyasDirector12 Aug 200818 Years 3 MonthsAs last reported
Susan Kling FinstonDirector25 Feb 200818 Years 8 MonthsAs last reported
Mihirkumar Arvind JoshiNominee Director31 Jul 200917 Years 3 MonthsAs last reported

Auditor

Amrita Therapeutics Limited is audited by AMAL DATT & ASSOCIATES LLP for the financial year 2018.

Auditor firmFinancial yearFirm registration number
AMAL DATT & ASSOCIATES LLPFY 2018100294W

Shareholding

The shareholding of Amrita Therapeutics Limited is on record for 4 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2018FY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Amrita Therapeutics Limited, buy the company report.

Deals & funding

Amrita Therapeutics Limited has 9 deals on record (5 funding rounds, 4 secondary share transfers), with disclosed funding of ₹3.77 Cr; the latest was in October 2015.

Total deals
9
Funding rounds
5
Secondary share transfers
4
Disclosed funding
₹3.77 Cr

Deals on record (5 of 9)

WhenDealAmountParties
Oct 2015Funding round₹2.37 CrInvestors: GVFL, Daniel Wolf Trust USA, an individual
Feb 2015Funding round₹28.3 LakhInvestors: an individual
Sep 2013Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Aug 2011Funding round₹15 LakhInvestors: GVFL
Oct 2010Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 2 individuals

To see the full deal history of Amrita Therapeutics Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Amrita Therapeutics Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Amrita Therapeutics has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAHCA2520R1ZLGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Amrita Therapeutics Limited, buy the company report.

Recent activity

Amrita Therapeutics Limited has 9 board changes on record since 2008: 3 appointments and 6 cessations. The latest: Himanshu Chimanlal Vyas ceased to be Director on 08 Nov 2019.

Ceased
Himanshu Chimanlal Vyas ceased to be Director.
Ceased
Mihirkumar Arvind Joshi ceased to be Nominee Director.
AGM
Amrita Therapeutics Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records.
Filing
Amrita Therapeutics Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Ahmedabad.
Ceased
Susan Kling Finston ceased to be Managing Director.
Ceased
Mohan Vinayak Harshey ceased to be Director.
Appointed
Mihirkumar Arvind Joshi was appointed as Nominee Director.
Ceased
Vishnu Rajaram Varshney ceased to be Director.
Ceased
Ananda Mohan Chakrabarty ceased to be Director.
Appointed
Himanshu Chimanlal Vyas was appointed as Director.
Appointed
Susan Kling Finston was appointed as Director.
Incorporation
25 Feb 2008
Amrita Therapeutics Limited was registered on 25 Feb 2008 with Roc Ahmedabad & aged 18 years 8 months as per MCA records.

Frequently asked questions

Amrita Therapeutics has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Amrita Therapeutics was a public limited company based in Ahmedabad, Gujarat, India. The company worked in biotechnology, within the life sciences industry. It was incorporated on 25 February 2008 and is registered under CIN U24239GJ2008PLC053030. The company has been struck off by the Registrar of Companies and is no longer operational.

Amrita Therapeutics had 3 directors:

The CIN (Corporate Identification Number) of Amrita Therapeutics is U24239GJ2008PLC053030. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Amrita Therapeutics is at Outer Room 11 Devipark Co – Op. Housing Society BH Lake View Appt. Vastrapur., Ahmedabad, Gujarat, India – 380054.

Amrita Therapeutics was incorporated on 25 February 2008. It is registered with the Registrar of Companies, Ahmedabad.

Amrita Therapeutics can be reached through the website amritatherapetics.com. Its registered office is in Ahmedabad, Gujarat, India.

The latest financial statements of Amrita Therapeutics on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from 2015 are in the company report.

The GSTIN of Amrita Therapeutics is 24AAHCA2520R1ZL, registered in Gujarat.

Amrita Therapeutics operated in the life sciences industry, in the biotechnology segment. It worked in this industry before it was struck off.